Ryan A. Doan

646 total citations
5 papers, 441 citations indexed

About

Ryan A. Doan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Ryan A. Doan has authored 5 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Oncology. Recurrent topics in Ryan A. Doan's work include Signaling Pathways in Disease (2 papers), RNA regulation and disease (2 papers) and Cancer Treatment and Pharmacology (2 papers). Ryan A. Doan is often cited by papers focused on Signaling Pathways in Disease (2 papers), RNA regulation and disease (2 papers) and Cancer Treatment and Pharmacology (2 papers). Ryan A. Doan collaborates with scholars based in United States and France. Ryan A. Doan's co-authors include Stefanie Geisler, Aaron DiAntonio, Jeffrey Milbrandt, Amy Strickland, Ahmet Höke, Xianrong Mao, Daniel W. Summers, Sara K. Pittman, Conrad C. Weihl and Antonio de Arriba Muñoz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Neuroscience.

In The Last Decade

Ryan A. Doan

4 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan A. Doan United States	4	185	114	111	95	80	5	441
Pascale Baden Germany	8	194 1.0×	55 0.5×	69 0.6×	71 0.7×	62 0.8×	9	492
Timothy A. Bolger United States	13	782 4.2×	100 0.9×	121 1.1×	51 0.5×	52 0.7×	16	915
Pítia Flores Ledur Brazil	10	217 1.2×	99 0.9×	36 0.3×	26 0.3×	34 0.4×	11	441
Jaclyn Nicole Le Grand France	8	365 2.0×	50 0.4×	87 0.8×	22 0.2×	68 0.8×	8	566
Alisia Carnemolla United Kingdom	9	268 1.4×	42 0.4×	116 1.0×	20 0.2×	107 1.3×	9	384
Nicolás W. Martínez Chile	7	243 1.3×	32 0.3×	179 1.6×	30 0.3×	83 1.0×	8	437
Shengyi Peng China	10	379 2.0×	83 0.7×	47 0.4×	26 0.3×	162 2.0×	11	608
Amit K. Patel United States	15	328 1.8×	44 0.4×	159 1.4×	17 0.2×	25 0.3×	19	598
Matthew A. White United Kingdom	9	116 0.6×	30 0.3×	66 0.6×	17 0.2×	26 0.3×	9	277
John Wizeman United States	7	134 0.7×	15 0.1×	28 0.3×	118 1.2×	24 0.3×	8	319

Countries citing papers authored by Ryan A. Doan

Since Specialization

Citations

This map shows the geographic impact of Ryan A. Doan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan A. Doan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan A. Doan more than expected).

Fields of papers citing papers by Ryan A. Doan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan A. Doan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan A. Doan. The network helps show where Ryan A. Doan may publish in the future.

Co-authorship network of co-authors of Ryan A. Doan

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan A. Doan. A scholar is included among the top collaborators of Ryan A. Doan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan A. Doan. Ryan A. Doan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Muñoz, Antonio de Arriba, Ryan A. Doan, Adam M. Coombs, et al.. (2025). TMEM63A, associated with hypomyelinating leukodystrophies, is an evolutionarily conserved regulator of myelination. Proceedings of the National Academy of Sciences. 122(30). e2507354122–e2507354122.

2.

Geisler, Stefanie, et al.. (2019). Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI Insight. 4(17). 108 indexed citations

3.

Geisler, Stefanie, Amy Strickland, Ryan A. Doan, et al.. (2019). Gene therapy targeting SARM1 blocks pathological axon degeneration in mice. The Journal of Experimental Medicine. 216(2). 294–303. 108 indexed citations

4.

Geisler, Stefanie, et al.. (2016). Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain. 139(12). 3092–3108. 202 indexed citations

5.

Geisler, Stefanie, Sara K. Pittman, Ryan A. Doan, et al.. (2016). TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance. Journal of Neuroscience. 36(17). 4681–4689. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact